Alerts
COVID-19 update
See our updated visitor policy, which now allows 1 visitor per patient during exams only. No visitors are allowed in treatment (applies at all locations). Only exceptions are patients with physical or mental disability.
Skip Navigation

Phase IIB pre-surgical trial of oral tamoxifen TAM versus transdermal 4-hydroxytamoxifen 4-OHT in women with DCIS of the breast

Brief Summary

Type:
Breast Cancer

Study Type:
Prevention

Phase:
II

ClinicalTrials.gov Identifier:
NCT02993159

Study #:
STUDY00144427

Start Date:
Jan 22, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02993159

View Complete Trial Details & Eligibility at ClinicalTrials.gov